Adaptive Biotechnologies Corp. (ADPT)
28.35
+0.98
(+3.58%)
USD |
NASDAQ |
Oct 02, 16:00
28.34
-0.02
(-0.05%)
Pre-Market: 20:00
Adaptive Biotechnologies Market Cap : 4.509B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.509B |
| October 01, 2026 | 4.353B |
| September 30, 2026 | 4.597B |
| September 29, 2026 | 4.576B |
| September 28, 2026 | 4.535B |
| September 25, 2026 | 4.681B |
| September 24, 2026 | 4.703B |
| September 23, 2026 | 4.436B |
| September 22, 2026 | 4.463B |
| September 21, 2026 | 4.431B |
| September 18, 2026 | 4.551B |
| September 17, 2026 | 4.541B |
| September 16, 2026 | 4.401B |
| September 15, 2026 | 4.244B |
| September 14, 2026 | 3.941B |
| September 11, 2026 | 3.849B |
| September 10, 2026 | 3.854B |
| September 09, 2026 | 3.884B |
| September 08, 2026 | 3.872B |
| September 04, 2026 | 3.862B |
| September 03, 2026 | 3.908B |
| September 02, 2026 | 3.922B |
| September 01, 2026 | 3.872B |
| August 31, 2026 | 3.964B |
| August 28, 2026 | 4.007B |
| Date | Value |
|---|---|
| August 27, 2026 | 4.206B |
| August 26, 2026 | 4.161B |
| August 25, 2026 | 4.175B |
| August 24, 2026 | 4.064B |
| August 21, 2026 | 4.134B |
| August 20, 2026 | 4.046B |
| August 19, 2026 | 4.054B |
| August 18, 2026 | 3.907B |
| August 17, 2026 | 3.940B |
| August 14, 2026 | 3.935B |
| August 13, 2026 | 3.891B |
| August 12, 2026 | 4.016B |
| August 11, 2026 | 4.039B |
| August 10, 2026 | 4.048B |
| August 07, 2026 | 3.965B |
| August 06, 2026 | 3.754B |
| August 05, 2026 | 3.913B |
| August 04, 2026 | 3.905B |
| August 03, 2026 | 3.676B |
| July 31, 2026 | 3.590B |
| July 30, 2026 | 3.846B |
| July 29, 2026 | 3.588B |
| July 28, 2026 | 3.582B |
| July 27, 2026 | 3.585B |
| July 24, 2026 | 3.556B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Personalis, Inc. | 1.732B |
| 10X Genomics, Inc. | 12.18B |
| Alamar Biosciences, Inc. (California) | 2.384B |
| Champions Oncology, Inc. | 68.76M |
| Medpace Holdings, Inc. | 16.69B |
Market Cap Related Metrics
| PS Ratio | 14.53 |
| Price to Book Value | 31.55 |
| Price | 28.35 |
| Earnings Yield | -1.44% |